We are looking for young people 2–17 years old to join a Crohn’s disease study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or IBD (including associated symptoms such as weight loss, unexplained weight loss, constant need to poop, chronic fatigue and/or canker sores), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
